Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
allergan
5
×
bristol-myers squibb
5
×
life sciences
national blog main
san diego blog main
san diego top stories
biotech
boston blog main
boston top stories
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
celgene
drug prices
genentech
gilead sciences
glaxosmithkline
ipo
What
bio
days
drugs
notes
roundup
abide
airport
annual
apocalypse
appetite
appointed
approved
august
beds
biotech
black
bread
busy
butter
buyout
cancer
cash
celgene
chief
data
decisions
developing
devices
diabetes
diamond’s
disease
diseases
drug
eli
executive
fallout
fatty
fda
finney
giant
Language
unset
Current search:
photo
×
allergan
×
" bristol-myers squibb "
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
